At Spark Therapeutics, a fully integrated commercial company dedicated to the discovery, development and provision of gene therapies, we challenge the inevitability of genetic diseases.
We are a diverse and experienced team. We are united and committed to removing barriers for people and families affected by genetic diseases. As our name implies, our one-time research therapies are designed to stimulate healthy biology and bring about life-changing transformations for people and families affected by genetic diseases. Spark is a member of the Roche Group.